0001140361-22-009256.txt : 20220311 0001140361-22-009256.hdr.sgml : 20220311 20220311210619 ACCESSION NUMBER: 0001140361-22-009256 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220311 FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cory David A CENTRAL INDEX KEY: 0001670137 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 22734910 MAIL ADDRESS: STREET 1: 350 CAMBRIDGE AVENUE, SUITE 350 CITY: PALO ALTO STATE: CA ZIP: 94306 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc. CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 361004130 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-279-9845 MAIL ADDRESS: STREET 1: 2155 PARK BOULEVARD CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: Celladon Corp DATE OF NAME CHANGE: 20041005 4 1 form4.xml FORM 4 X0306 4 2022-03-11 0001305253 Eiger BioPharmaceuticals, Inc. EIGR 0001670137 Cory David A C/O EIGER BIOPHARMACEUTICALS, INC. 2155 PARK BLVD. PALO ALTO CA 94306 true true President and CEO Common Stock 2022-03-11 4 A 0 47000 0 A 169183 D Stock Option (Right to Buy) 5.1 2022-03-11 4 A 0 281000 0 A 2032-03-10 Common Stock 281000 281000 D Represents shares underlying Restricted Stock Units award that will vest as to 33.3% on each of the first, second and third anniversaries of the grant date of March 11, 2022. The option vests in 48 equal monthly installments commencing on the grant date of March 11, 2022, subject to the Reporting Person's continuous service as of such date. Includes shares purchased under the Issuer's Employee Stock Purchase Plans as follows: 1,378 shares on September 5, 2020, 1,459 shares on September 3, 2021, and 1,500 shares on March 5, 2022. /s/ Sriram Ryali, Attorney-in-Fact 2022-03-11